# ulcerative colitis (UC) - gpt-5.6-luna

- Benchmark system: E2seq + Agent RAG
- Repeat: 6
- Task type: DISEASE-STATE
- Tissue / sample source: colonic mucosal tissue
- Comparison or endpoint: ulcerative colitis versus healthy control
- Answer input cohort: Discovery/Core only
- Selected items: 100
- Input fields: gene name, effect size (log2FC/HR), P value, FDR
- E2seq Agent RAG: enabled
- Conversation memory: disabled
- Thinking mode: disabled
- Held-out validation data in prompt/RAG: no
- Model API: OpenAI / gpt-5.6-luna
- Message SHA-256: 478acec7ab00f0e9bda085b6ecab7aa16a2bc8aa5cde3f2ba8fb71b2af94f79a
- Response HTTP status: 200
- Prompt tokens: 48067
- Completion tokens: 17474
- Reasoning tokens: 0
- Total tokens: 65541
- API requests reported: 3
- Elapsed seconds: 160.628
- RAG status: reused_or_ready
- RAG records/genes reported: 100
- RAG elapsed seconds: 1095.213
- Question handoff seconds: 1109.559
- Final benchmark system: E2seq; file rank 4/5; original repeat 6; model vendor: OpenAI

---
## Data-quality and evidence status

The uploaded results show a strong, coherent disease-state contrast: **100 unique genes**, with **40 upregulated and 60 downregulated**, and every selected gene has **FDR ≤ 0.01**. However, the ledger also reports **175 retained input rows and 43 duplicated genes/probes**. Several entries combine multiple symbols or probe annotations, such as `CYP2B7P|CYP2B6`, `NAT8B|NAT8`, and `UBD|GABBR1`. This warrants verification of probe-to-gene mapping and duplicate handling before interpreting the exact gene-level ranking.

The very small P values and uniformly significant results are biologically plausible for a large tissue contrast but may also reflect strong tissue-composition differences, batch structure, or highly separated disease and control groups. The statistical effects below are therefore treated as authoritative for this dataset, while **external statistical validation was not performed**: no independent-cohort effect sizes, P values, or FDR values were supplied.

The available pathway and network records are contextual annotations. The reported GO/KEGG recurrence and 50 STRING edges were not recomputed during synthesis and do not constitute formal enrichment statistics.

## 1. Overall biological interpretation

The profile is most consistent with **inflamed and structurally injured colonic mucosa undergoing epithelial functional loss, innate immune activation, and wound-remodeling responses**.

Three features are particularly prominent:

1. **Inflammatory and antimicrobial activation:** `DUOX2` and `DUOXA2`, chemokines `CXCL1`, `CXCL2`, and `CXCL3`, `S100A8`, `LCN2`, `CHI3L1`, `PLA2G2A`, and `PI3` are upregulated. This suggests epithelial and myeloid inflammatory signaling with potential neutrophil recruitment and antimicrobial stress.
2. **Loss of epithelial transport and metabolic functions:** `AQP8`, `AQP7`, `SLC16A1`, `SLC38A4`, `SLC51A`, `HMGCS2`, `ABCB11`, `G6PC`, and several xenobiotic or lipid-associated genes are downregulated. This is compatible with impaired fluid handling, nutrient/metabolite transport, bile-acid-related functions, and differentiated epithelial metabolism.
3. **Mucosal remodeling and repair:** `MMP3`, `TNC`, `TIMP1`, `PRRX1`, `PDPN`, `TGM2`, `SERPINB5`, and `CDH3` are increased, indicating extracellular-matrix turnover, stromal activation, epithelial restitution, or altered wound-healing architecture.

The upregulation of `CTLA4` and an immunoglobulin-containing transcript additionally suggests increased adaptive immune representation, although these findings cannot distinguish true transcriptional induction from increased immune-cell abundance.

## 2. Core biological programs

### Program 1 — Innate inflammatory, epithelial-stress, and antimicrobial response

- **Direction:** Upregulated in UC.
- **Major supporting genes:** `DUOX2` (+4.666), `DUOXA2` (+2.892), `S100A8` (+3.799), `LCN2` (+2.668), `CXCL1` (+3.456), `CXCL2` (+2.799), `CXCL3` (+2.330), `PLA2G2A` (+1.535), `PI3` (+2.208), `CHI3L1` (+4.590), `IL1RN` (+2.876).
- **Relevant pathway terminology:** KEGG **IL-17 signaling pathway**; GO terms related to inflammatory response, antimicrobial response, and chemokine activity are biologically appropriate, although a new formal GO enrichment calculation was not performed.
- **Interpretation:** The coordinated increase of three related CXC chemokines, epithelial oxidase components, antimicrobial proteins, and inflammatory alarmins is stronger than a single-gene disease association. It is compatible with epithelial sensing of luminal stress and recruitment or activation of neutrophil-like inflammatory cells.
- **Evidence strength:** **Strong direct dataset evidence; supported hypothesis biologically.** The multiple concordant genes and the supplied IL-17 pathway annotation support a coherent inflammatory program.
- **Limitations:** The transcriptome cannot establish whether epithelial cells, infiltrating myeloid cells, or both generate these signals. `S100A8`, in particular, may be strongly affected by neutrophil or monocyte abundance. IL-17 pathway membership is contextual and is not an independent replication statistic.

### Program 2 — Impaired epithelial water, solute, and barrier transport

- **Direction:** Predominantly downregulated, with selected transporter exceptions.
- **Major supporting genes:** `AQP8` (−4.417), `AQP7` (−2.322), `SLC16A1` (−2.375), `SLC38A4` (−3.067), `SLC51A` (−3.711), `SLC23A1` (−2.402), `SLC23A3` (−1.929), `MEP1B` (−2.991), `DEFB1` (−2.305), while `SLC6A14` is strongly upregulated (+4.849).
- **Relevant standardized terms:** GO **Fluid Transport (GO:0042044)**, **Water Transport (GO:0006833)**, and **Carboxylic Acid Transport (GO:0046942)**; KEGG **Bile secretion**.
- **Interpretation:** The coordinated loss of aquaporin, monocarboxylate, amino-acid, bile-acid-related, and epithelial defense transcripts suggests disruption of differentiated epithelial transport and barrier-associated functions. The opposite direction of `SLC6A14` indicates that the response is not a uniform loss of all transporters; it may represent compensatory amino-acid transport or a change in the abundance of a specific epithelial subpopulation.
- **Evidence strength:** **Strong direct dataset evidence for a transport-related state change; supported hypothesis for epithelial dysfunction.** The supplied GO and KEGG records are concordant contextual evidence.
- **Limitations:** Reduced expression may reflect epithelial erosion, crypt remodeling, or altered cell composition rather than cell-intrinsic suppression. Transport transcript changes do not prove impaired transport physiology.

### Program 3 — Loss of differentiated epithelial metabolic and detoxification functions

- **Direction:** Broadly downregulated.
- **Major supporting genes:** `HMGCS2` (−3.445), `G6PC` (−1.523), `CYP2B6` (−2.777), `CYP2B7P|CYP2B6` (−2.804), `ABCB11` (−1.148), `LIPC` (−1.574), `GBA3` (−3.002), `HSD3B2` (−2.770), `NAT8B` (−1.306), `ACSF2` (−1.927), and `UGT2A3` (−2.677).
- **Relevant terminology:** KEGG **Bile secretion** and metabolic transport; lipid, bile-acid, and xenobiotic metabolism are appropriate functional descriptions, but no pathway-specific statistical enrichment was supplied.
- **Interpretation:** The pattern suggests loss or suppression of metabolic programs characteristic of differentiated colonic epithelial cells, including ketogenesis-related `HMGCS2`, glucose handling, lipid metabolism, and detoxification-associated genes. It may represent epithelial dedifferentiation during active inflammation.
- **Evidence strength:** **Moderate-to-strong direct dataset evidence for coordinated metabolic downregulation; exploratory mechanistic interpretation.**
- **Limitations:** Many of these genes are cell-type and differentiation-state markers. The data cannot distinguish inflammatory repression from replacement of mature epithelial cells by regenerative or infiltrating populations. The grouped and duplicated CYP/NAT8 annotations require technical review.

### Program 4 — Extracellular-matrix remodeling, stromal activation, and wound repair

- **Direction:** Upregulated.
- **Major supporting genes:** `MMP3` (+4.642), `TNC` (+2.579), `TIMP1` (+1.969), `PRRX1` (+2.907), `PDPN` (+2.539), `TGM2` (+1.907), `SERPINB5` (+3.294), `CDH3` (+2.293), `FILIP1L` (+1.864), and `IGDCC4` (+1.861).
- **Relevant terminology:** GO extracellular-region and extracellular-matrix organization; Reactome extracellular-matrix remodeling would be appropriate if formally tested.
- **Interpretation:** The simultaneous increase in matrix-associated genes, a matrix metalloproteinase, its inhibitor, matricellular `TNC`, and stromal/repair-associated markers is consistent with active mucosal injury and remodeling. `MMP3` and `TIMP1` increasing together suggests elevated matrix turnover rather than a simple unidirectional proteolytic state.
- **Evidence strength:** **Strong direct dataset evidence for a remodeling-associated state; supported hypothesis for stromal and epithelial repair involvement.**
- **Limitations:** These genes may originate from fibroblasts, epithelial cells, endothelial cells, or infiltrating cells. The transcript data do not establish fibrosis, irreversible remodeling, or causality.

### Program 5 — Adaptive immune representation and immune-regulatory response

- **Direction:** Upregulated, with uncertain cellular origin.
- **Major supporting genes:** `CTLA4` (+2.616), the immunoglobulin-containing transcript `LOC100290146|IGHV4-31|IGHM|IGHG1|IGH` (+1.891), `DAPP1` (+2.204), `CD55` (+2.038), `UBD|GABBR1` (+2.580), `IFI16` (+1.386), `SOCS3` (+2.786), and `IRAK3` (+1.782).
- **Relevant terminology:** Immune-cell signaling, lymphocyte activation/regulation, and innate immune negative-feedback processes. A specific adaptive-immune pathway was not formally enriched in the supplied results.
- **Interpretation:** Increased `CTLA4` and immunoglobulin-related signal is compatible with greater lymphocyte or plasma-cell representation, while `SOCS3`, `IRAK3`, and `IL1RN` suggest feedback inhibition alongside inflammation. This combination may reflect an inflamed mucosa containing both effector and regulatory immune components.
- **Evidence strength:** **Moderate direct dataset evidence; exploratory for cell-state interpretation.**
- **Limitations:** Bulk mucosal data cannot determine whether `CTLA4` reflects regulatory T cells, activated conventional T cells, or cell-composition shifts. The immunoglobulin transcript is a composite annotation and should not be interpreted as a single well-defined gene.

## 3. Key genes and interaction modules

1. **`DUOX2`–`DUOXA2` epithelial oxidative-stress module**  
   Both are upregulated: `DUOX2` log2FC **4.665965**, FDR **4.4476281e-26**; `DUOXA2` log2FC **2.8920434**, FDR **1.116691e-10**. They are pathway/functionally related components of epithelial reactive-oxygen and antimicrobial defense. This is a **functional and regulatory/activation relationship**, not evidence from the supplied records of a direct physical interaction in this dataset. Interpretation: **supported hypothesis**, not proof that DUOX2 activity causes UC injury.

2. **`CXCL1`–`CXCL2`–`CXCL3` chemokine module**  
   All three are upregulated, with log2FC values **3.4560327**, **2.799141**, and **2.3295316**, respectively. STRING records connect this group through the chemokine receptor **CXCR2**, and OmniPath-related records connect `CXCL1`/`CXCL2` to **ADRA2A**. These are primarily **ligand–receptor and pathway relationships**; they should not be described as direct physical interactions among the three chemokines. This is a strong candidate for neutrophil-recruiting inflammatory activity.

3. **`S100A8`–`LCN2` inflammatory antimicrobial module**  
   `S100A8` is upregulated at log2FC **3.798764**, and `LCN2` at **2.667762**. Both are compatible with inflamed mucosa and myeloid/epithelial antimicrobial responses. STRING records for `LCN2` include `MMP9`, `LTF`, and `SLC22A17`; these are **database-supported functional or physical-association records**, not necessarily direct interactions with `S100A8`. Cell composition is a major alternative explanation.

4. **`AQP8`–`AQP7` epithelial water-transport module**  
   Both are downregulated: `AQP8` log2FC **−4.4171899**, FDR **1.6032447e-13**; `AQP7` log2FC **−2.321569**, FDR **4.0370572e-20**. The relationship is **pathway co-membership and shared transporter function**, not a demonstrated direct protein interaction. Supplied Reactome annotations support aquaporin-mediated transport for `AQP7`. This module is a useful epithelial-function readout.

5. **Solute and bile-related transport module**  
   `SLC38A4`, `SLC16A1`, `SLC51A`, `SLC23A1`, `ABCB11`, and `ABCG2` are downregulated, while `SLC6A14` is strongly upregulated. This is a **functional/pathway relationship** involving epithelial solute, metabolite, and transporter activity, not a direct interaction network. The mixed direction supports remodeling or compensatory adaptation rather than global transporter failure.

6. **`HMGCS2`–`G6PC`–`ABCB11` epithelial metabolic module**  
   These genes are all downregulated, with log2FC values **−3.4453213**, **−1.5233675**, and **−1.1484579**. Their relationship is **metabolic pathway co-membership and shared differentiated epithelial function**, not a direct physical interaction. The module supports loss of mature epithelial metabolic activity.

7. **`MMP3`–`TNC`–`TIMP1` remodeling module**  
   `MMP3` is strongly upregulated (+4.6419437), with increased `TNC` (+2.5785036) and `TIMP1` (+1.9694608). `ITGB1` is linked in the supplied STRING network to `FREM2`, `TGM2`, and `TNC`; this is a **network-level functional association**, and the records do not establish direct binding among all module members. The module indicates matrix turnover and wound repair.

8. **`PRRX1`–`PDPN`–`FREM2` stromal/repair module**  
   `PRRX1` and `PDPN` are upregulated, whereas `FREM2` is downregulated. These genes are related through **stromal, extracellular-matrix, and tissue-architecture functions**. The discordant `FREM2` direction cautions against interpreting this as a uniform fibroblast activation signature.

9. **`CTLA4` and immunoglobulin-containing transcript**  
   `CTLA4` (+2.6157893) and `LOC100290146|IGHV4-31|IGHM|IGHG1|IGH` (+1.8913027) suggest increased adaptive immune representation. Their relationship is **cellular-context co-occurrence**, not a direct interaction. The interpretation remains composition-sensitive.

10. **`BRINP3`**  
    `BRINP3` is downregulated, log2FC **−2.1328504**, FDR **6.952725e-12**. A question-specific literature record, PMID **25171508**, reports underexpression of `BRINP3` in UC mucosal transcriptomics, which is directionally concordant with this dataset. This is external literature support, not independent statistical replication of the current cohort. Its precise mechanism in UC remains **insufficiently established**.

## 4. Validation priorities

### 1. Epithelial DUOX2/DUOXA2 and oxidative-antimicrobial activity  
- **Class:** Mechanistic hypothesis  
- **Why prioritize:** Both oxidase components are strongly upregulated, and the surrounding inflammatory/antimicrobial program is coherent.
- **Current evidence:** `DUOX2` log2FC **4.665965**, FDR **4.4476281e-26**; `DUOXA2` log2FC **2.8920434**, FDR **1.116691e-10**, plus increased `LCN2`, `PI3`, `S100A8`, and chemokines.
- **External support:** The supplied pathway annotations and disease literature context support epithelial inflammatory plausibility, but no external functional experiment or independent cohort statistic was supplied.
- **Next step:** Perform epithelial-cell-resolved RNA or protein localization, measure DUOX2-dependent ROS and antimicrobial activity in organoids or primary colonic epithelial cells, and test whether inflammatory stimulation reproduces the signature.
- **Assessment:** **Supported hypothesis**, not established causality.

### 2. CXCL1/2/3–CXCR2 inflammatory recruitment axis  
- **Class:** Interaction / network hypothesis  
- **Why prioritize:** Three related chemokines are independently upregulated, and the supplied STRING/ligand-receptor records converge on CXCR2-related signaling.
- **Current evidence:** `CXCL1`, `CXCL2`, and `CXCL3` are all significantly increased, with FDR values from **1.1517617e-15** to **2.5059046e-11**.
- **External support:** STRING and OmniPath records support receptor/pathway relationships; these sources may overlap in literature and database inference and are not independent cohort validation.
- **Next step:** Confirm chemokine and CXCR2 protein localization, quantify neutrophil recruitment in ex vivo mucosal or organoid–immune co-cultures, and test pathway perturbation experimentally.
- **Assessment:** **Supported hypothesis**.

### 3. Epithelial transport and metabolic failure as a disease-state biomarker  
- **Class:** Biomarker  
- **Why prioritize:** The combined reduction of `AQP8`, `AQP7`, `SLC51A`, `SLC38A4`, `SLC16A1`, and `HMGCS2` is more informative than any single marker.
- **Current evidence:** `AQP8` log2FC **−4.4171899** and `HMGCS2` log2FC **−3.4453213**, both with FDR below **1.2e-16**, alongside multiple related downregulated genes.
- **External support:** GO transport and KEGG bile-secretion annotations support plausibility; no independent diagnostic or clinical performance statistic was supplied.
- **Next step:** Validate in an independent UC cohort stratified by endoscopic activity and treatment status, and compare transcript levels with epithelial localization, stool water handling, metabolite profiles, or barrier-permeability assays.
- **Assessment:** **Exploratory hypothesis** until independently validated.

### 4. Matrix-remodeling and wound-repair state  
- **Class:** Mechanistic hypothesis  
- **Why prioritize:** `MMP3`, `TNC`, `TIMP1`, `PRRX1`, `PDPN`, and `TGM2` collectively support active tissue remodeling.
- **Current evidence:** `MMP3` log2FC **4.6419437**, FDR **5.3985035e-14**; `TNC` log2FC **2.5785036**, FDR **2.5059046e-11**; `TIMP1` log2FC **1.9694608**, FDR **1.8098232e-17**.
- **External support:** Extracellular-region annotations and STRING relationships involving `ITGB1`, `TNC`, `TGM2`, and `FREM2` support network plausibility, but do not prove fibrosis or causation.
- **Next step:** Use spatial transcriptomics or immunohistochemistry to identify the producing cell types, together with matrix-deposition and wound-closure assays.
- **Assessment:** **Supported hypothesis**.

### 5. Cell-composition and disease-activity check  
- **Class:** Confounding or composition check  
- **Why prioritize:** The simultaneous increase of `S100A8`, immunoglobulin transcripts, `CTLA4`, `PDPN`, and matrix-associated genes could reflect altered proportions of myeloid, lymphoid, stromal, and epithelial cells.
- **Current evidence:** The bulk mucosal signature contains immune, stromal, inflammatory, and epithelial programs with opposing transporter/metabolic changes.
- **External support:** Tissue-expression and disease-association records provide plausibility but do not resolve cellular origin; external statistical validation is unavailable.
- **Next step:** Apply single-cell or spatial deconvolution, include histologic inflammation and treatment covariates, and validate representative proteins by cell-type-specific staining.
- **Assessment:** **Established methodological priority**, while the magnitude and direction of cell-composition effects remain uncertain.

## 5. Evidence grounding and conflicts

- **Direct dataset evidence:** All effect sizes, P values, and FDR values above come from the supplied differential-expression table and are the strongest evidence for this cohort.
- **Pathway/ontology evidence:** The supplied GO terms for fluid, water, and carboxylic-acid transport and the KEGG annotations for IL-17 signaling and bile secretion are concordant with the inflammatory and epithelial-transport interpretation. They were not newly calculated here and do not establish enrichment significance.
- **Network evidence:** STRING and OmniPath records support selected functional, ligand–receptor, or network relationships. Relationship type is source-dependent; network edges should not automatically be interpreted as direct physical binding.
- **Disease and literature evidence:** PMID **25171508** supports concordant underexpression of `BRINP3` in UC mucosal transcriptomics. PMID **41029776** and Europe PMC record **38059894** describe computational UC biomarker or treatment-response analyses, but the supplied records do not provide an independent statistic that can be compared with this cohort.
- **Genetic, tissue, therapeutic, and clinical records:** These provide plausibility and prioritization context but are not replication. The evidence pack explicitly reports **independent-cohort validation not available**.
- **Conflicts:** The main internal complexity is not a direct contradiction but mixed biology: inflammatory and repair genes are increased while epithelial transport and metabolic genes are decreased, and `SLC6A14` is increased despite broad transporter loss. This is compatible with cell-state heterogeneity or compensatory remodeling. The discordance of `FREM2` with other remodeling genes also argues against treating the stromal program as uniform.

## 6. Limitations and alternative explanations

1. **Cellular composition:** Bulk mucosal RNA can conflate epithelial loss, immune infiltration, stromal expansion, and true within-cell regulation. Single-cell/spatial profiling and cell-type-specific protein validation are needed.
2. **Disease activity and treatment exposure:** Active inflammation, corticosteroids, biologics, antibiotics, or other treatments could alter chemokine, antimicrobial, and epithelial-repair genes. Stratification by endoscopic activity and medication is important.
3. **Technical duplication and annotation ambiguity:** The 43 duplicated genes/probes and composite labels may inflate apparent evidence for some loci or obscure the correct transcript. Re-map probes, collapse duplicate measurements transparently, and check whether grouped symbols represent independent probes or aliases.
4. **Batch and cohort structure:** The extreme significance across all 100 selected genes could partly reflect batch, platform, center, or case–control separation. Principal-component inspection, covariate adjustment, and permutation or sensitivity analyses should be performed on the original expression matrix.
5. **Association versus causation:** The results describe a UC-associated mucosal state. They do not establish that `DUOX2`, chemokines, `MMP3`, transport loss, or any other candidate initiates disease or will respond therapeutically to a targeted intervention.

Overall, the most defensible interpretation is that this UC mucosal profile combines **innate inflammatory activation, epithelial antimicrobial stress, loss of differentiated transport/metabolic functions, and extracellular-matrix remodeling**, with adaptive immune and cell-composition effects requiring explicit resolution.

E2seq statistical audit: selected=100, ledger=100, RAG records=100, numeric claims checked=0, external claims checked=0, external mismatches=0, status=passed.

Answer model API: OpenAI / gpt-5.6-luna

Source coverage (gene sources = selected items with records / selected RAG items; literature sources = articles / queries)
Online APIs: alliance 94/100 selected items (records returned); cbioportal 87/100 selected items (records returned); chembl 40/100 selected items (partially returned; some queries failed); civic 7/100 selected items (records returned); clinicaltrials 51/100 selected items (records returned); clinvar 90/100 selected items (records returned); ensembl 55/100 selected items (partially returned; some queries failed); europepmc 936 articles / initial full-cohort RAG 100 queries + 4 current-round queries; gtex 91/100 selected items (records returned); gwas 100/100 selected items (records returned); hpa 85/100 selected items (records returned); humanbase 87/100 selected items (records returned); intact 85/100 selected items (records returned); mygene 93/100 selected items (records returned); omnipath 45/100 selected items (records returned); opentargets 92/100 selected items (records returned); pubmed 750 articles / initial full-cohort RAG 100 queries + 3 current-round queries; quickgo 87/100 selected items (records returned); reactome 100/100 selected items (records returned); uniprot 88/100 selected items (records returned)
Local databases: gutmgene 8/100 selected items (records returned); hmdb 46/100 selected items (records returned); string 85/100 selected items (records returned); trrust 31/100 selected items (records returned)
